Atopic dermatitis (eczema) trials in United States
77 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
No phaseRecruitingResearch participation
Sodium in the Skin and Atopic Dermatitis
- Where
- San Francisco
- Age
- 50 years and over
- People
- 90
- Run by
- University of California, San Francisco
See details and how to joinNCT06998446Registry updated 2026-07-14
Phase 1RecruitingTrial-stage medicine
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Where
- Chicago, Cincinnati, Denver, Madison, New York, Rochester, San Diego
- Age
- 6 years and over
- People
- 86
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06504160Registry updated 2026-07-02
No phaseRecruitingResearch participation
CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
- Where
- Waltham
- Age
- 10 years to 15 years
- People
- 1,500
- Run by
- CorEvitas
See details and how to joinNCT06238765Registry updated 2026-06-29
Phase 2RecruitingTrial-stage medicine
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
- Where
- Bellaire, Fountain Valley, Fremont, Los Angeles, Sacramento, Webster
- Age
- 18 years to 65 years
- People
- 114 worldwide
- Run by
- Oneness Biotech Co., Ltd.
See details and how to joinNCT06397911Registry updated 2026-06-15
Phase 4RecruitingTrial-stage medicine
Molecular Signatures of Cutaneous Dupilumab Response
- Where
- San Francisco
- Age
- 18 years and over
- People
- 15
- Run by
- University of California, San Francisco
See details and how to joinNCT05858619Registry updated 2026-06-04
Phase 4Not yet recruitingTrial-stage medicine
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
- Where
- San Francisco
- Age
- 18 years and over
- People
- 10
- Run by
- University of California, San Francisco
See details and how to joinNCT07352566Registry updated 2026-06-03
No phaseRecruitingResearch participation
Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism
- Where
- Boston
- Age
- 6 years to 65 years
- People
- 111
- Run by
- Boston Children's Hospital
See details and how to joinNCT04455906Registry updated 2026-05-18
Phase 1RecruitingTrial-stage medicine
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
- Where
- Arkansas City, Boardman, Bountiful, Fremont, Philadelphia, Plainfield
- Age
- 18 years to 65 years
- People
- 149 worldwide
- Run by
- Sitryx Therapeutics Ltd
See details and how to joinNCT07558668Registry updated 2026-04-30
Phase 4RecruitingTrial-stage medicine
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
- Where
- Chicago
- Age
- 6 years to 17 years
- People
- 40
- Run by
- Northwestern University
See details and how to joinNCT05042258Registry updated 2026-04-27
No phaseEnrolling by invitationResearch participation
Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis
- Where
- Philadelphia
- People
- 300
- Run by
- University of Pennsylvania
See details and how to joinNCT06464133Registry updated 2026-04-24
No phaseRecruitingResearch participation
Registry for Systemic Eczema Treatments
- Where
- Baltimore
- Age
- 1 year to 26 years
- People
- 400
- Run by
- Johns Hopkins University
See details and how to joinNCT06136767Registry updated 2026-04-07
No phaseRecruitingResearch participation
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Where
- Auburn, Auburn Hills, Birmingham, Bluffton, Boca Raton, Bountiful, Brighton, Caledonia, Castle Rock, Cedar Park, Chicago, Columbia, Coral Gables, Corona, Cutler Bay, Dallas, Dayton, East Syracuse, Edinburg, Fairfield, Fountain Valley, Fremont, Glenn Dale, Grandville, Grapevine, Gresham, Hollywood, Indianapolis, Jupiter, Las Vegas, Lee's Summit, Los Angeles, Miami, Milford, Morgantown, Mount Kisco, Newport Beach, New York, North Miami Beach, Oakland Park, Philadelphia, Phoenix, Portsmouth, Rockville, Santa Monica, St. Petersburg, Sugar Land, Tampa, Thousand Oaks, Troy, Tucson, Vienna, Waco, West Lafayette
- Age
- 12 years and over
- People
- 1,000 worldwide
- Run by
- Galderma R&D
See details and how to joinNCT06988605Registry updated 2026-03-13
Phase 4Not yet recruitingTrial-stage medicine
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
- Where
- Boston
- Age
- 6 years and over
- People
- 100
- Run by
- Boston Children's Hospital
See details and how to joinNCT06397781Registry updated 2026-03-10
Phase 2RecruitingTrial-stage medicine
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
- Where
- South San Francisco
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- Corvus Pharmaceuticals, Inc.
See details and how to joinNCT07441395EU 2025-524384-20-00Registry updated 2026-03-05
No phaseRecruitingResearch participation
Flourish: Exploring the Early Infant Gut Microbiome
- Where
- Austin
- Age
- 0 months to 3 months
- People
- 250
- Run by
- Seeding Inc
See details and how to joinNCT07333482Registry updated 2026-02-24
No phaseRecruitingResearch participation
Allergy and Immunology Natural History Study
- Where
- New York
- Age
- Up to 99 years
- People
- 10,000
- Run by
- Columbia University
See details and how to joinNCT05584488Registry updated 2026-02-04
Phase 1RecruitingTrial-stage medicine
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
- Where
- Dallas, Fargo
- Age
- 18 years and over
- People
- 48 worldwide
- Run by
- LAPIX Therapeutics Inc.
See details and how to joinNCT06982352Registry updated 2025-12-19
No phaseRecruitingResearch participation
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
- Where
- Morrisville
- Age
- 15 years to 50 years
- People
- 958
- Run by
- Incyte Corporation
See details and how to joinNCT06259669Registry updated 2025-12-11
No phaseRecruitingResearch participation
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- Where
- Morrisville
- Age
- 14 years and over
- People
- 5,621
- Run by
- Incyte Corporation
See details and how to joinNCT06627335Registry updated 2025-12-11
No phaseRecruitingResearch participation
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
- Where
- New York
- Age
- 0 years and over
- People
- 400
- Run by
- Pfizer
See details and how to joinNCT05721937Registry updated 2025-12-09
No phaseRecruitingResearch participation
Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
- Where
- Ann Arbor
- Age
- 10 years to 55 years
- People
- 200
- Run by
- University of Michigan
See details and how to joinNCT06300697Registry updated 2025-11-25
Phase 4RecruitingTrial-stage medicine
Ethnic Differences in Mechanisms of Action of Dupilumab
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 30
- Run by
- University of Michigan
See details and how to joinNCT05268107Registry updated 2025-11-06
Phase 1RecruitingTrial-stage medicine
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
- Where
- Camp Hill, North Little Rock, Philadelphia
- Age
- 18 years and over
- People
- 45
- Run by
- Brexogen Inc.
See details and how to joinNCT06055361Registry updated 2025-09-19
No phaseRecruitingResearch participation
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
- Where
- La Jolla
- People
- 900
- Run by
- University of California, San Diego
See details and how to joinNCT05938478Registry updated 2025-01-28
Phase 2RecruitingTrial-stage medicine
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
- Where
- Ann Arbor, Sacramento
- Age
- 18 years to 75 years
- People
- 60
- Run by
- AbbVie
See details and how to joinNCT06524635Registry updated 2025-01-24
All Atopic dermatitis (eczema) trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.